BridgeMD
New treatment option for Age Related Cataracts
Official title Intraindividual Comparison of EMO IOLs
ClinicalTrials.gov ID: NCT05822089
What this study is testing
- What it's testing
- The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 100
You may be able to join if
- Bilateral age-related cataract planned for phacoemulsification extraction and posterior IOL implantation
- Age 50 to 100
- Visual potential in both eyes of 20/25 or better as determined by investigators estimation
- Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
- Irregular Astigmatism (Acrysof IQ Vivity IOL, IC-8 Apthera IOL)
You likely can't join if
- Preceding intraocular surgery or ocular trauma
- Relevant other ophthalmic diseases that particularly effects the zonular apparatus (such as severe pseudoexfoliation syndrome, preceding...
- Pupil diameter \< 2.0 mm (photopic)
- Laser treatment
- Uncontrolled systemic or ocular disease
- Pregnancy/Nursing
See the full eligibility criteria
- Bilateral age-related cataract planned for phacoemulsification extraction and posterior IOL implantation
- Age 50 to 100
- Visual potential in both eyes of 20/25 or better as determined by investigators estimation
- Normal findings in medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
- Irregular Astigmatism (Acrysof IQ Vivity IOL, IC-8 Apthera IOL)
- postoperativ binocular best corrected distance visual acuity (BCVA) ≥ 1.0 decimal (Arm ten (X))
- Standard cataract surgery with bilateral implantation of a monofocal IOL (Vivinex XC1 or Vivinex XY1) (Arm ten (X))
- Preceding intraocular surgery or ocular trauma
- Relevant other ophthalmic diseases that particularly effects the zonular apparatus (such as severe pseudoexfoliation syndrome, preceding cryocoagulation, trauma)
- Pupil diameter \< 2.0 mm (photopic)
- Laser treatment
- Uncontrolled systemic or ocular disease
- Pregnancy/Nursing
- childbearing ability
The study team makes the final eligibility decision.
Where it's taking place
- Vienna, Austria
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Vienna, Austria. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.